DBV Technologies (DBVT) Net Cash Flow (QoQ) (2020 - 2026)
DBV Technologies (DBVT) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -234.43% |
| Mar 31, 2026 | -67.93% |
| Dec 31, 2025 | 478.52% |
| Sep 30, 2025 | -139.16% |
| Jun 30, 2025 | 513.43% |
| Mar 31, 2025 | -86.39% |
| Dec 31, 2024 | 52.20% |
| Sep 30, 2024 | 34.45% |
| Jun 30, 2024 | 6.70% |
| Mar 31, 2024 | -162.31% |
| Dec 31, 2023 | 32.17% |
| Sep 30, 2023 | -14.62% |
| Jun 30, 2023 | 13.10% |
| Mar 31, 2023 | 14.00% |
| Dec 31, 2022 | -16.84% |
| Sep 30, 2022 | -111.20% |
| Jun 30, 2022 | 11,647.22% |
| Mar 31, 2022 | 91.52% |
| Dec 31, 2021 | 21.53% |
| Sep 30, 2021 | 18.40% |